A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis
Clinical trial NCT00479427 · COMPLETED
Trial details
- NCT number
- NCT00479427
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-06
- Primary completion
- 2007-10-09
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.